BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16862185)

  • 1. Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation.
    Ji Z; Degerny C; Vintonenko N; Deheuninck J; Foveau B; Leroy C; Coll J; Tulasne D; Baert JL; Fafeur V
    Oncogene; 2007 Jan; 26(3):395-406. PubMed ID: 16862185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIASy-mediated repression of the Ets-1 is independent of its sumoylation.
    Nishida T; Terashima M; Fukami K
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1536-46. PubMed ID: 16729975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multiple post-translational modifications implied in the gene expression regulation: example of the sumoylation of Ets factors].
    de Launoit Y; Degerny C; Wohlkonig A; Baert JL
    Bull Mem Acad R Med Belg; 2007; 162(5-6):299-305; discussion 306. PubMed ID: 18404999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sumoylation and proteasomal activity determine the transactivation properties of the mineralocorticoid receptor.
    Tirard M; Almeida OF; Hutzler P; Melchior F; Michaelidis TM
    Mol Cell Endocrinol; 2007 Mar; 268(1-2):20-9. PubMed ID: 17314004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repression of Smad4 transcriptional activity by SUMO modification.
    Long J; Wang G; He D; Liu F
    Biochem J; 2004 Apr; 379(Pt 1):23-9. PubMed ID: 14750902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMOylation can regulate the activity of ETS-like transcription factor 4.
    Kaikkonen S; Makkonen H; Rytinki M; Palvimo JJ
    Biochim Biophys Acta; 2010 Aug; 1799(8):555-60. PubMed ID: 20637912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role for SUMO modification in facilitating transcriptional repression by BKLF.
    Perdomo J; Verger A; Turner J; Crossley M
    Mol Cell Biol; 2005 Feb; 25(4):1549-59. PubMed ID: 15684403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
    Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
    J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beads-on-a-string, characterization of ETS-1 sumoylated within its flexible N-terminal sequence.
    Macauley MS; Errington WJ; Schärpf M; Mackereth CD; Blaszczak AG; Graves BJ; McIntosh LP
    J Biol Chem; 2006 Feb; 281(7):4164-72. PubMed ID: 16319071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIASy controls ubiquitination-dependent proteasomal degradation of Ets-1.
    Nishida T; Terashima M; Fukami K; Yamada Y
    Biochem J; 2007 Aug; 405(3):481-8. PubMed ID: 17456046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIASy-mediated sumoylation of Yin Yang 1 depends on their interaction but not the RING finger.
    Deng Z; Wan M; Sui G
    Mol Cell Biol; 2007 May; 27(10):3780-92. PubMed ID: 17353273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An extended consensus motif enhances the specificity of substrate modification by SUMO.
    Yang SH; Galanis A; Witty J; Sharrocks AD
    EMBO J; 2006 Nov; 25(21):5083-93. PubMed ID: 17036045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.
    Spengler ML; Kennett SB; Moorefield KS; Simmons SO; Brattain MG; Horowitz JM
    Cell Signal; 2005 Feb; 17(2):153-66. PubMed ID: 15494207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a novel posttranslational modification in neuronal nitric oxide synthase by small ubiquitin-related modifier-1.
    Watanabe M; Itoh K
    Biochim Biophys Acta; 2011 Jul; 1814(7):900-7. PubMed ID: 21545853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
    Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
    Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of E1AF transcriptional activity by sumoylation and PIASy.
    Nishida T; Terashima M; Fukami K; Yamada Y
    Biochem Biophys Res Commun; 2007 Aug; 360(1):226-32. PubMed ID: 17585876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.
    Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L
    Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.
    Wu R; Fang J; Liu M; A J; Liu J; Chen W; Li J; Ma G; Zhang Z; Zhang B; Fu L; Dong JT
    J Biol Chem; 2020 May; 295(19):6741-6753. PubMed ID: 32249212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMO modification regulates the transcriptional activity of MAML1.
    Lindberg MJ; Popko-Scibor AE; Hansson ML; Wallberg AE
    FASEB J; 2010 Jul; 24(7):2396-404. PubMed ID: 20203086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional activity of megakaryoblastic leukemia 1 (MKL1) is repressed by SUMO modification.
    Nakagawa K; Kuzumaki N
    Genes Cells; 2005 Aug; 10(8):835-50. PubMed ID: 16098147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.